Human Tumor Sequencing Project

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01608230

Acronym

HuTS

Enrollment

Registered

2012-05-31

Start date

2010-04-30

Completion date

2014-04-30

Last updated

2014-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

This study is being done to learn more about genetic mutations in cancer cells and to find out how the development of new technologies can increase knowledge of these mutations and possibly predict an individual's response to certain treatments.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosis of a solid tumor or blood borne cancer * 18 years or older * Eligible to have blood drawn

Design outcomes

Primary

Measure	Time frame
Determine biomarkers of clinical utility and copy number variants through genetic analysis.	four years

Countries

United States

Outcome results